C230052I12Rik Inhibitors

C230052I12Rik, although not fully characterized, emerges as a crucial player in cellular dynamics, participating in intricate signaling pathways. This protein potentially contributes to cellular responses, growth, and survival by engaging with various signaling cascades, making it an intriguing subject for further investigation. The inhibitors listed above target specific pathways associated with C230052I12Rik, providing potential avenues for modulation. For instance, A769662 and GSK621, AMPK activators, indirectly influence C230052I12Rik by activating AMPK, thereby modulating cellular energy balance and metabolic pathways. SU6656, a Src kinase inhibitor, and BAY 61-3606, a Syk inhibitor, modulate kinase pathways, potentially impacting cellular processes associated with C230052I12Rik.

Furthermore, VX-680 and ZM-447439, Aurora kinase inhibitors, and SB 203580, a p38 MAPK inhibitor, intervene in specific pathways linked to cellular dynamics, influencing processes associated with C230052I12Rik. CP-91149, a CDK2 inhibitor, and PP2, a Src kinase inhibitor, modulate kinase pathways, potentially affecting cellular processes connected to C230052I12Rik. PP242, a mTOR inhibitor, and SB 216763, a GSK-3 inhibitor, disrupt the mTOR and GSK-3 pathways, respectively, potentially influencing cellular processes related to C230052I12Rik. Collectively, these inhibitors provide valuable tools to unravel the intricate cellular dynamics governed by C230052I12Rik, paving the way for further exploration in cellular biology research.